We sincerely thank the 651 peer reviewers who completed manuscript reviews for JAMA Psychiatry in 2024.

US physicians’ elevated risk for depression has been well established in the past decade—however, the risk of physician suicide relative to the general public remains unclear. In this issue of JAMA Psychiatry, Makhija and colleagues use data from 97 915 US suicides from 2017 to 2021, drawn from the US National Violent Death Reporting System, to estimate sex-specific suicide incidence rates among physicians and the general population. The authors’ findings indicate that rates of suicide are higher among female physicians and lower among male physicians compared to sex-matched nonphysicians in the general population.

This Viewpoint explores the shift from the process-oriented concept of evidence-based practicing toward the development and distribution of evidence-based practices within the sphere of mental health care.

The TTT (Triple TBS Thirty-Minute Interval) randomized clinical trial is a triple-blinded, sham-controlled study conducted among adults with treatment-resistant depression (TRD) evaluating the efficacy and safety of a pragmatic accelerated theta-burst stimulation protocol for TRD.

This meta-analysis examines reports of blood leukocyte subpopulations in patients with schizophrenia vs healthy controls, examining disease- and treatment-related differences and potential confounders, to provide evidence to support or challenge the immune hypothesis of schizophrenia.

This survey study analyzes 2 years of data from a cross-section of adults in the United States to determine the trajectories of sports gambling frequency and alcohol-related problems over time and the associations between these trajectories.

The Original Investigation titled “An Approach to Providing Timely Mental Health Services to Diverse Youth Populations,” published online February 26, 2025, was changed to open access status under a CC-BY license. This article was corrected online.

This cohort study evaluates whether an intervention in youth services in Canada increased the numbers of youth referred, appointments scheduled within 72 hours of referral, and youths receiving services within 30 days of the first appointment.

This cohort study evaluates whether maternal inflammatory proteins during pregnancy are associated with the risk of neurodevelopmental disorders and executive functions in middle childhood.

This mendelian randomization study identifies circulating proteins associated with risk for schizophrenia, bipolar disorder, major depressive disorder, and cognitive task performance.

When I give presentations about JAMA Psychiatry, people often ask me what our “strategy” is and how we decide what papers to publish. I respond that our guiding lights are scientific rigor and clinical relevance. This has never been truer than at the present time, when medical research and practice are under scrutiny like never before. We strive to publish original research that will stand the test of time, informed opinion pieces about current challenges, and insightful review articles taking stock of progress. When we succeed in that goal, our readers recognize that our journal showcases the most impactful developments in our field. In 2024, we published a key phase 3 clinical trial on the first new antipsychotic medication with a nondopaminergic mechanism of action in history (xanomeline-trospium) and a study on the positive impact of GLP-1 receptor agonists on alcohol use disorder outcomes in a national registry. We also covered ongoing debates concerning revisions of psychiatric nosology and continued to cover all aspects of the therapeutic potential and pitfalls of psychedelics and even devoted 3 of our popular podcasts to the topic.

This Viewpoint discusses developing better evidence about appropriate use of stimulants, understanding and reducing nonmedical use of these medications, and responding to shortages.

In Reply We thank Xie for his comments regarding our study published in a recent issue of JAMA Psychiatry and for drawing attention to several important sociodemographic groups, including those defined by immigrant status, disability status, sexual orientation, and gender identity with limited access to psychotherapy. Given evidence of mental health care inequities across these groups, a better understanding of their trends in outpatient psychotherapy use could inform policies to address critical impediments to mental health care equity.

To the Editor The study by Olfson and colleagues provides valuable insights into how sociodemographic factors intersect with psychotherapy use patterns, particularly in the context of the growing role of teletherapy. However, several limitations restrict the scope and impact of the study, particularly with respect to the demographic factors considered, the granularity of the variables captured, and the scope of digital interventions.

Mission Statement: JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians and researchers in psychiatry, mental health, behavioral science, and allied fields. The journal seeks to inform its readers, to stimulate discussion into the nature, causes, treatment, and public health importance of mental illness, and to promote equity and justice for those affected by mental illness and for society.

This cohort study compares suicide incidence among physicians vs the general US population by sex and associated factors.

This cohort study investigates the predisposing characteristics associated with treatment-resistant depression.

This narrative review discusses the impact of expectancy effects and functional unblinding on treatment responses in randomized clinical trials of treatments in psychiatry.

This diagnostic study uses machine learning to predict diagnostic progression to schizophrenia or bipolar disorder among patients receiving psychiatric services in Denmark.

This Viewpoint discusses addressing women’s anger after trauma.